Comparison of biosimilars to originator mAbs

Collaboration with: Evidentic (Germany)
Since: 2019

Through this collaboration, our customers get access to advanced analytical methods for the characterization of biosimilars and comparison to the originator biologics. Together, Alphalyse and Evidentic focus on solving challenges with the research and development of biosimilars.

Original EU-licensed drugs sold as consumables

Evidentic is the first company that offers original EU-licensed drugs, based on therapeutic antibodies, for purchase in small amounts as research consumables. This makes it possible for researchers to source different batches of therapeutic antibodies as consumables – instead of buying expensive original vials.

Talk with our experts

  • This field is for validation purposes and should be left unchanged.
Improve your protein research
Subscribe to our newsletter and get 3 tips that will instantly improve your protein analysis results

Receive monthly emails with news, tips, case stories
and offers for protein analysis
© Copyright Alphalyse 2002 - 2023. All rights reserved.